82 results
Page 2 of 5
S-4/A
ewplc
13 Jul 21
Registration of securities issued in business combination transactions (amended)
4:41pm
S-4
f6raix b8fi2
1 Jul 21
Registration of securities issued in business combination transactions
12:00am
8-K
EX-99.1
5q9n2z gj82
22 Jun 21
Acasti Pharma Provides Fiscal 2021 Year-End Business Update
7:00am
8-K
jtw64
17 May 21
Acasti Intends to Request Hearing Before Nasdaq Panel to Present Plan of Compliance
7:11am
8-K
EX-99.1
b893u
17 May 21
Acasti Intends to Request Hearing Before Nasdaq Panel to Present Plan of Compliance
7:11am
8-K
EX-2.1
chc31rquu838
7 May 21
Entry into a Material Definitive Agreement
7:09am
425
EX-2.1
qllh x2s7o4i6
7 May 21
Business combination disclosure
7:08am
8-K
EX-99.1
g628ktbqyetriy y88
9 Feb 21
Acasti Pharma Announces Results for Third Quarter of Fiscal 2021
4:35pm
8-K
EX-99.1
b53qoce7ey176 7k
16 Nov 20
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2021
7:05am
424B5
h8zlpv0pav5y4 vph4
7 Jul 20
Prospectus supplement for primary offering
4:32pm
10-K
c52 17jky2e
29 Jun 20
Annual report
4:02pm
S-3
EX-1.2
sfytl z32foi2
29 Jun 20
Shelf registration
12:00am
S-3
ftgfxcxwfyo
29 Jun 20
Shelf registration
12:00am
8-K
wxpw4r
20 Apr 20
Acasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in Canada
4:05pm
6-K
EX-99.1
m8cg7tcgku
28 Feb 20
Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements
5:00pm
F-3
cb1hrehjnawu28h61l
7 Aug 19
Shelf registration (foreign)
12:00am
6-K
EX-99.1
rc4otf mhx
6 Aug 19
Notice of Annual and Special Meeting of Shareholders
12:00am